STOCK TITAN

SmartKem (NASDAQ: SMTK) issues $2.5M Ferrox note and $4M private raise

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

SmartKem, Inc. entered into a new convertible bridge loan and completed an additional private financing. The company funded Ferrox Critical Minerals with a $2,500,000.00 Convertible Promissory Note bearing 5.0% annual interest and maturing on December 31, 2026, plus a $200,000.00 origination fee, tighter covenants, and broad rights of first refusal and exclusivity on major Ferrox transactions.

Separately, SmartKem closed an Additional Closing under its Series A Preferred Stock Securities Purchase Agreement, issuing 5,000 shares of Series A convertible preferred stock and 10,753,615 warrants for aggregate cash proceeds of approximately $4.0 million in a private placement relying on Regulation D and Section 4(a)(2) exemptions.

Positive

  • None.

Negative

  • None.

Insights

SmartKem extends strategic credit to Ferrox while raising $4M in preferred equity financing.

SmartKem provided Ferrox Critical Minerals a $2,500,000.00 convertible bridge loan at 5.0% interest, maturing on December 31, 2026. The note includes a $200,000.00 origination fee, potential default interest of 15%, and a $4,500.00-per-day default management fee.

The note is convertible into Ferrox ordinary shares at the lower of fair market value or an equity valuation of $80,000,000 on a fully diluted basis, giving SmartKem equity upside. Extensive negative covenants, a right of first refusal on Fundamental Transactions, and exclusivity through December 31, 2026 strengthen its position.

On the funding side, SmartKem completed an Additional Closing of its Series A Preferred Stock private placement, issuing 5,000 preferred shares and 10,753,615 warrants for approximately $4.0 million in cash proceeds. The securities were sold under Section 4(a)(2) and Rule 506 of Regulation D, indicating an institutional, exempt offering structure.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Ferrox bridge note principal $2,500,000.00 Original principal amount of Convertible Promissory Note
Base interest rate 5.0% per annum Interest on Ferrox Convertible Promissory Note
Default interest rate 15% per annum Interest rate upon event of default under the note
Origination fee $200,000.00 Fee paid to SmartKem for funding the Ferrox note
Default management fee $4,500.00 per day Daily fee payable to SmartKem after an event of default
Ferrox equity valuation reference $80,000,000 Equity value cap used for conversion pricing, fully diluted
Additional Closing proceeds approximately $4.0 million Cash from 5,000 Series A shares and 10,753,615 warrants
Preferred financing capacity $17,129,200.00 million Aggregate purchase price capacity under Preferred Stock Purchase Agreement
Convertible Promissory Note financial
"which loan was evidenced by that certain Convertible Promissory Note (the “Note”)"
A convertible promissory note is a loan a company takes now that can later be turned into shares instead of being repaid in cash. Think of it as lending money with the option to accept ownership in the business down the road; that matters to investors because it affects who gets paid first, how much ownership existing shareholders keep, and the company’s future valuation and cash needs. Terms such as conversion price, interest and maturity determine the financial impact.
right of first refusal financial
"The Note also contains a right of first refusal in favor of the Company"
A right of first refusal gives an existing shareholder or party the chance to buy an asset or shares before the owner can sell them to someone else. Think of it like being offered the first option to buy a house when the owner decides to sell; it matters to investors because it can limit who can acquire a stake, slow or block transactions, and affect the price and liquidity of an investment by restricting open-market sales or new buyers.
Fundamental Transaction financial
"each, a “Fundamental Transaction”"
Series A convertible preferred stock financial
"shares of the Company’s Series A convertible preferred stock, par value $0.001 per share"
Series A convertible preferred stock is a class of shares sold in an early funding round that gives investors a mix of protection and upside: it pays a priority claim over common shares if the company is sold or closes, but can be converted into ordinary shares to share in future growth. Think of it like a hybrid between a safer stake and a ticket to ownership; it matters to investors because it affects who controls the company, how future gains are split, and how much their investment is protected from downside.
Regulation D regulatory
"in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D"
Regulation D is a set of rules that govern how companies can raise money from investors without going through the full process required for public stock offerings. It provides simplified options for private placements, making it easier for companies to seek investments from a smaller group of investors. For investors, it offers opportunities to invest in private companies, often with fewer restrictions, but also with different levels of risk and disclosure.
Emerging growth company regulatory
"Emerging growth company x"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001817760 0001817760 2026-06-22 2026-06-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 22, 2026

 

SmartKem, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware 001-42115 85-1083654

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

 

3 Germay Drive, Unit 4 #1029

Wilmington, DE, 19804

(Address of principal executive offices, including zip code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of exchange on which registered
Common Stock, par value $0.0001 per share   SMTK   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b - 2 of the Securities Exchange Act of 1934 (§240.12b - 2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

  

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement

 

On June 22, 2026, SmartKem, Inc. (the “Company”) funded an additional bridge loan to Ferrox Critical Minerals, a British Virgin Islands company (“Ferrox”), in the original principal amount of $2,500,000.00, which loan was evidenced by that certain Convertible Promissory Note (the “Note”) issued by Ferrox to the Company. The obligations evidenced by the Note shall accrued interest at a rate of 5.0% per annum and will mature on December 31, 2026. Pursuant to the terms of the Note, the Company was paid an originate fee of $200,000.00. Upon an event of default (as defined in the Note), the Company will be paid a default management fee of $4,500.00 per day and the interest rate shall increase to 15% per annum.

 

The obligations under the Note are convertible into ordinary shares of Ferrox (“Ordinary Shares”) at any time by the Company at a price per Ordinary Share equal to the lower (i) the fair market value of an Ordinary Share at the time of conversion as determined by an independent appraisal firm or (ii) the value of an Ordinary Share determined based on a total equity value of Ferrox of $80,000,000, on a fully-diluted basis. The conversion price is subject to customary adjustments for stock dividends, stock splits and stock combinations.

 

The Note also contains customary negative covenants restricting Ferrox’s ability to, among other things, redeem any of its equity securities, incur or repay indebtedness, make or declare any dividends or distributions on its equity securities, sell, lease or otherwise dispose of its assets, amend its charter or enter into any transactions with its affiliates.

 

The Note also contains a right of first refusal in favor of the Company on any (i) direct or indirect transfer, sale, lease, license or encumbrance of all or any portion of the capital stock or assets of Ferrox or any of its subsidiaries (other than (x) inventory to be sold in the ordinary course of business consistent with past practice and (y) sales of immaterial or obsolete assets), (ii) any merger, consolidation or other business combination relating to Ferrox or any of its subsidiaries to the extent such transaction constitutes a change of control, (iii) any recapitalization, reorganization or any other extraordinary business transaction involving or otherwise relating to Ferrox or any of its subsidiaries to the extent such transaction constitutes a change of control or (iv) equity issuance or debt incurrence involving Ferrox or any of its subsidiaries (each, a “Fundamental Transaction”).

 

Ferrox has also granted the Company exclusivity with respect to any Fundamental Transaction through December 31, 2026.

 

The Note is additional to the previously announced convertible promissory note issued by Ferrox to the Company on April 23, 2026.

 

The foregoing descriptions of the terms of the Note do not purport to be complete and are subject to, and qualified in their entirety by reference to, the Note which is annexed hereto as Exhibit 4.1 and is incorporated herein by reference.

 

 

Item 3.02 Unregistered Sales of Equity Securities.

 

Private Placement

 

Additional Closing under Securities Purchase Agreement

 

As previously announced, on March 30, 2026, the Company, entered into a Securities Purchase Agreement (the "Preferred Stock Purchase Agreement") with certain institutional investors (collectively, the "Buyers"). Pursuant to the Preferred Stock Purchase Agreement, up to 21,411.5 shares of the Company’s Series A convertible preferred stock, par value $0.001 per share (the “Series A Preferred Stock”) and accompanying warrants (“Warrants”) to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) may be purchased for an aggregate purchase price of up to $17,129,200.00 million in one or more closings.

 

 

As previously announced, on March 30, 2026 at the initial closing, pursuant to the Preferred Stock Purchase Agreement, the Company issued and sold, and certain Buyers purchased, in a private placement: (i) 11,411.5 shares of the Series A Preferred Stock, with a stated value of $1,000 per share, convertible into shares of Common Stock and (ii) warrants to purchase up to 23,251,960 shares of Common Stock (the "Warrants").

 

Pursuant to the Preferred Stock Purchase Agreement, the Buyers have the right, severally, subject to the satisfaction of certain conditions, to require the Company to participate in one or more additional closings for the purchase of up to an aggregate of 10,000 additional shares of Series A Preferred Stock and Warrants (each such transaction, an “Additional Closing”).

 

On June 22, 2026, at an Additional Closing pursuant to the Preferred Stock Purchase Agreement, the Company issued and sold, and certain Buyers purchased, in a private placement: 5,000 shares of the Series A Preferred Stock and 10,753,615 Warrants to purchase shares of Common Stock for aggregate proceeds of approximately $4.0 million, paid in cash.

 

All such securities will not be registered under the Securities Act in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder, or under any state securities laws. The Company relied on this exemption from registration in entering into the Securities Purchase Agreement and the Company will rely upon this exemption from registration in issuing such securities based in part on representations made by the investors in the Securities Purchase Agreement. The securities may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. Neither this Current Report on Form 8-K, nor the exhibits attached hereto, is an offer to sell or the solicitation of an offer to buy the securities described herein.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibits Description
4.1 Convertible Promissory Note issued by Ferrox Critical Minerals to SmartKem, Inc. on June 22, 2026
104 Cover Page Interactive Data File (Embedded within the Inline XBRL document)

 

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  SMARTKEM, INC.
     
Dated: June 26, 2026 By: /s/ Barbra C. Keck
    Barbra C. Keck
    Chief Financial Officer

 

 

FAQ

What bridge loan did SmartKem (SMTK) provide to Ferrox Critical Minerals?

SmartKem funded a new bridge loan to Ferrox Critical Minerals with an original principal of $2,500,000.00. The Convertible Promissory Note carries 5.0% annual interest, matures on December 31, 2026, and includes a $200,000.00 origination fee plus enhanced default fees and covenants.

What are the conversion terms of SmartKem’s Ferrox Convertible Promissory Note?

The Ferrox note is convertible into ordinary shares at a price per share equal to the lower of fair market value or a value based on an $80,000,000 total equity valuation on a fully diluted basis. The conversion price adjusts for stock dividends, splits, and combinations.

What additional private placement did SmartKem (SMTK) complete on June 22, 2026?

On June 22, 2026, SmartKem completed an Additional Closing under its Series A Preferred Stock Securities Purchase Agreement, issuing 5,000 Series A preferred shares and 10,753,615 warrants for aggregate cash proceeds of approximately $4.0 million in a private placement to institutional investors.

What is the total capacity of SmartKem’s Series A Preferred Stock financing?

Under the Securities Purchase Agreement, up to 21,411.5 shares of Series A convertible preferred stock and accompanying warrants may be purchased for an aggregate purchase price of up to $17,129,200.00 million, in one or more closings as investors exercise their rights for Additional Closings.

What rights and protections does SmartKem receive under the Ferrox note?

SmartKem receives negative covenants limiting Ferrox’s actions on debt, dividends, asset sales, and affiliate transactions, plus a right of first refusal and exclusivity on specified Fundamental Transactions involving Ferrox or its subsidiaries through December 31, 2026, enhancing its strategic control.

Under what securities law exemptions were SmartKem’s new securities issued?

SmartKem’s Series A preferred shares and warrants were sold in a private placement relying on Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D. These exemptions require qualified investors and restrict public resale absent registration or another applicable exemption.

Filing Exhibits & Attachments

4 documents